SERVICIO DE SALUD DE CASTILLA LA MANCHA

Their core work

SESCAM is the public health service of the Castilla-La Mancha region in Spain, operating a network of hospitals and clinical facilities. Within H2020, they contribute clinical expertise and patient access for neuroscience and regenerative medicine research — particularly around spinal cord injury treatment, stroke recovery, and neural interface technologies. More recently, they have expanded into integrated care solutions for elderly patients with multiple chronic conditions and dementia, reflecting their role as a real-world clinical testing ground for advanced therapeutic and digital health interventions.

What they specialise in

How they've shifted over time

SESCAM's early H2020 work (2015-2017) centred on regenerative medicine — stem cell therapy for stroke, nanomedicine for spinal cord injury, and experimental neuroprosthetics. From 2018 onward, their focus shifted toward implantable neural interfaces and bidirectional brain-computer systems, reflecting the maturation of their neural repair work into more applied, device-oriented research. Their most recent project (CAREPATH, 2021) marks a notable pivot toward digital health and integrated elderly care, suggesting a broadening from lab-stage neuroscience toward population-level clinical implementation.

SESCAM is moving from experimental neuroscience toward applied clinical solutions — both in neural devices and in digitally-supported chronic care management for aging populations.

How they like to work

SESCAM primarily operates as a consortium partner (4 of 5 projects), contributing clinical expertise and patient access rather than leading research design. They coordinated one project (Neurofibres, their largest at EUR 952K), showing they can lead when the topic aligns closely with their clinical strengths. With 56 unique partners across 13 countries, they connect broadly across European research networks rather than clustering around a few repeat collaborators.

SESCAM has collaborated with 56 distinct partners across 13 countries, indicating a wide European network built through diverse neuroscience and health projects. Their connections span academic, clinical, and technology partners across Western and Southern Europe.

What sets them apart

SESCAM offers something rare in EU consortia: a full regional public health system that can serve as a real-world clinical validation site for advanced therapies and digital health tools. Unlike university hospitals that focus on research excellence, SESCAM brings routine clinical practice, diverse patient populations, and the operational reality of a public healthcare provider. For anyone developing neural devices, regenerative therapies, or integrated elderly care solutions, they provide the bridge between laboratory results and real-world clinical deployment.

Highlights from their portfolio

• Neurofibres
  Their only coordinated project and largest funding (EUR 952K), developing biofunctionalised electroconducting microfibres for spinal cord injury — shows deep institutional commitment to neural repair.
• CAREPATH
  Most recent project (2021-2025) and a strategic pivot toward integrated digital care for multimorbid elderly patients with dementia, signalling a new direction for the organization.
• ByAxon
  Combines nanotechnology, magnetoresistance sensors, and half-metallic perovskite oxides for neural reconnection — an unusually multidisciplinary approach to spinal cord injury.